336 related articles for article (PubMed ID: 10750765)
1. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery.
Wong BI; McLean RF; Fremes SE; Deemar KA; Harrington EM; Christakis GT; Goldman BS
Ann Thorac Surg; 2000 Mar; 69(3):808-16. PubMed ID: 10750765
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization.
Mongan PD; Brown RS; Thwaites BK
Anesth Analg; 1998 Aug; 87(2):258-65. PubMed ID: 9706913
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
6. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
7. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
Yasim A; Aşik R; Atahan E
Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
[TBL] [Abstract][Full Text] [Related]
8. Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients.
Bernet F; Carrel T; Marbet G; Skarvan K; Stulz P
J Card Surg; 1999; 14(2):92-7. PubMed ID: 10709819
[TBL] [Abstract][Full Text] [Related]
9. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
[TBL] [Abstract][Full Text] [Related]
10. Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding.
Nuttall GA; Oliver WC; Ereth MH; Santrach PJ; Bryant SC; Orszulak TA; Schaff HV
Anesthesiology; 2000 Mar; 92(3):674-82. PubMed ID: 10719945
[TBL] [Abstract][Full Text] [Related]
11. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
[TBL] [Abstract][Full Text] [Related]
12. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
[TBL] [Abstract][Full Text] [Related]
13. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
[TBL] [Abstract][Full Text] [Related]
14. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
[TBL] [Abstract][Full Text] [Related]
16. [Transfusion requirements, morbidity and mortality in cardiac surgery and the use of antifibrinolytic agents: a comparison of aprotinin and tranexamic acid].
Muedra V; Delás F; Villalonga V; Gómez M; Sánchez F; Llopis JE
Rev Esp Anestesiol Reanim; 2011 Mar; 58(3):140-6. PubMed ID: 21534287
[TBL] [Abstract][Full Text] [Related]
17. Major transfusions remain frequent despite the generalized use of tranexamic acid: an audit of 3322 patients undergoing cardiac surgery.
Stevens LM; Noiseux N; Prieto I; Hardy JF
Transfusion; 2016 Jul; 56(7):1857-65. PubMed ID: 27112920
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.
Wang G; Xie G; Jiang T; Wang Y; Wang W; Ji H; Liu M; Chen L; Li L
Anesth Analg; 2012 Aug; 115(2):239-43. PubMed ID: 21737704
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery.
Graham EM; Atz AM; Gillis J; Desantis SM; Haney AL; Deardorff RL; Uber WE; Reeves ST; McGowan FX; Bradley SM; Spinale FG
J Thorac Cardiovasc Surg; 2012 May; 143(5):1069-76. PubMed ID: 22075061
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
